https://betalanalysgranskaren.se/logg/ 2026-10-27T19:53:38.845Z https://betalanalysgranskaren.se/logg/#bolag_tillagt%7Canalysguiden%7Cdistrict-metals 2026-10-27T19:53:38.845Z

District Metals hos Analysguiden.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalysguiden%7Cbyggpartner-gruppen%7Chttps%3A%2F%2Fwww.aktiespararna.se%2Fanalyser%2Fvd-intervju-byggpartner-gruppen-2026 2026-10-27T19:53:38.845Z

ByggPartner Gruppen hos Analysguiden. VD-intervju Byggpartner Gruppen Q3-26.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cvhcorp%7Cadvenica%7Chttps%3A%2F%2Fwww.vhcorp.se%2Ftjanster%2Fmarknadsfokus%2Fadvenica%2Fadvenica-reaching-a-milestone-with-nato 2026-10-27T09:00:46.952Z

Advenica hos Västra Hamnen Corporate Finance. Advenica: Reaching a milestone with NATO.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cxvivo-perfusion%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fxvivo-perfusion-q3-review-heart-opportunity-approaching 2026-10-27T09:00:46.952Z

Xvivo Perfusion hos Redeye. Xvivo Perfusion (Q3 Review): Heart opportunity approaching.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cvitrolife%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fvitrolife-q3-review-technologies-leads-the-way 2026-10-27T09:00:46.952Z

Vitrolife hos Redeye. Vitrolife (Q3 review): Technologies leads the way.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cvitec-software-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fvitec-q3-review-manda-engine-set-to-accelerate 2026-10-27T09:00:46.952Z

Vitec Software Group hos Redeye. Vitec (Q3 Review): M&A engine set to accelerate.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cvertiseit%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fvertiseit-q3-review-organic-arr-pick-up-and-swift-scala-integration-support-the-case 2026-10-27T09:00:46.952Z

Vertiseit hos Redeye. Vertiseit (Q3 Review): Organic ARR Pick-Up and Swift Scala Integration Support the Case.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Ctruecaller%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Ftruecaller-strong-q3-preliminary-figures-india-tax-bill-now-has-a-number 2026-10-27T09:00:46.952Z

Truecaller hos Redeye. Truecaller: Strong Q3 preliminary figures – India tax bill now has a number.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cstille%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fstille-q3-improving-profitability-and-strong-cash-flow-generation 2026-10-27T09:00:46.952Z

Stille hos Redeye. Stille Q3: Improving profitability and strong cash flow generation.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cssh-communications-security%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fssh-q3-preview-a-soft-quarter-expected-focus-on-order-timing 2026-10-27T09:00:46.952Z

SSH Communications Security hos Redeye. SSH (Q3 Preview): A Soft Quarter Expected, Focus on Order Timing.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Csenzime%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fsenzime-q3-preview-a-rebound-needed-to-turn-the-tide 2026-10-27T09:00:46.952Z

Senzime hos Redeye. Senzime (Q3 Preview): A rebound needed to turn the tide.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Craysearch%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fraysearch-q3-preview-the-moment-of-truth 2026-10-27T09:00:46.952Z

Raysearch hos Redeye. RaySearch (Q3 preview): The moment of truth.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cq-beyond%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fq-beyond-cut-2026-guidance-suggests-soft-q4 2026-10-27T09:00:46.952Z

q.beyond hos Redeye. q.beyond: Cut 2026 guidance suggests soft Q4.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cplejd%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fplejd-q3-review-norway-overloads-the-circuit 2026-10-27T09:00:46.952Z

Plejd hos Redeye. Plejd (Q3 Review): Norway Overloads the Circuit.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cphysitrack%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fphysitrack-q3-review-back-to-growth-transition-from-add-on-to-platform 2026-10-27T09:00:46.952Z

Physitrack hos Redeye. Physitrack (Q3 Review): Back to growth: transition from add-on to platform.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Coxe-marine%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Foxe-marine-q3-review-upbeat-q3-but-overall-demand-remains-soft 2026-10-27T09:00:46.952Z

OXE Marine hos Redeye. OXE Marine (Q3 Review): Upbeat Q3 but overall demand remains soft.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cnanologica%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fnanologica-new-ceo-updated-strategy-and-sek110-5m-rights-issue 2026-10-27T09:00:46.952Z

Nanologica hos Redeye. Nanologica: New CEO, updated strategy and SEK110.5m rights issue.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cmodelon%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fmodelon-q3-review-arr-turns-growth-back-on-the-agenda 2026-10-27T09:00:46.952Z

Modelon hos Redeye. Modelon (Q3 Review): ARR turns – growth back on the agenda.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Clitium%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Flitium-q3-review-profit-delivered-free-shipping-on-growth-1 2026-10-27T09:00:46.952Z

Litium hos Redeye. Litium (Q3 Review): Profit Delivered, Free Shipping on Growth.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Clitium%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Flitium-q3-review-profit-delivered-free-shipping-on-growth 2026-10-27T09:00:46.952Z

Litium hos Redeye. Litium (Q3 Review): Profit Delivered, Free Shipping on Growth.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Clime-technologies%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Flime-q3-review-steady-delivery-in-a-cautious-market-ai-adds-upside 2026-10-27T09:00:46.952Z

Lime Technologies hos Redeye. Lime (Q3 Review): Steady delivery in a cautious market, AI adds upside.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Ci-tech%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fi-tech-q3-review-navigating-eu-bpr-with-a-strong-core 2026-10-27T09:00:46.952Z

I-tech hos Redeye. I-Tech (Q3 Review): Navigating EU-BPR With a Strong Core.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Chexatronic-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fhexatronic-q3-review-strong-quarter-all-over-with-data-center-in-the-lead 2026-10-27T09:00:46.952Z

Hexatronic Group hos Redeye. Hexatronic (Q3 Review): Strong quarter all over, with Data Center in the lead.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Chacksaw%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fhacksaw-q3-preview-slower-growth-momentum-creates-uncertainty 2026-10-27T09:00:46.952Z

Hacksaw hos Redeye. Hacksaw (Q3 Preview): Slower growth momentum creates uncertainty.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cguldbrev%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fguldbrev-q3-review-downgrades-on-softer-volumes-and-expansion-costs-yet-valuation-remains-attractive 2026-10-27T09:00:46.952Z

Guldbrev hos Redeye. Guldbrev (Q3 Review): Downgrades on Softer Volumes and Expansion costs, Yet Valuation Remains Attractive.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cgenovis%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fweekly-edge-case-genovis 2026-10-27T09:00:46.952Z

Genovis hos Redeye. Weekly Edge Case – Genovis.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cgapwaves%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fgapwaves-q3-review-volume-beats-price-lags 2026-10-27T09:00:46.952Z

Gapwaves hos Redeye. Gapwaves (Q3 Review): Volume beats, price lags.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cfreemelt%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Ffreemelt-sek-28m-contract-win 2026-10-27T09:00:46.952Z

Freemelt hos Redeye. Freemelt: SEK 28m contract win.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cexpres2ion-biotech-holding%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fexpres2ion-biotech-phase-i-fully-enrolled-readout-in-q1-2027 2026-10-27T09:00:46.952Z

ExpreS2ion Biotech Holding hos Redeye. ExpreS2ion Biotech: Phase I fully enrolled, readout in Q1 2027.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cevolution%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fevolution-q3-review-stable-quarter-brazil-creates-uncertainty 2026-10-27T09:00:46.952Z

Evolution hos Redeye. Evolution (Q3 Review): Stable quarter, Brazil creates uncertainty.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cependion%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fependion-q3-review-operating-leverage-kicking-in 2026-10-27T09:00:46.952Z

Ependion hos Redeye. Ependion (Q3 Review): Operating leverage kicking in.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cenea%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fenea-q3-review-cheap-waiting-for-growth 2026-10-27T09:00:46.952Z

Enea hos Redeye. Enea (Q3 Review): Cheap, waiting for growth.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Ceg7%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Feg7-q3-preview-soft-aliens-launch-partly-offset-by-solid-portfolio 2026-10-27T09:00:46.952Z

EG7 hos Redeye. EG7 (Q3 Preview): Soft Aliens launch partly offset by solid portfolio.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cdynavox-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fdynavox-group-q3-review-medicaid-headwinds-margins-intact 2026-10-27T09:00:46.952Z

Dynavox Group hos Redeye. Dynavox Group (Q3 Review): Medicaid headwinds, margins intact.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cbonesupport%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fbonesupport-q3-review-a-compelling-setup-for-2027 2026-10-27T09:00:46.952Z

BONESUPPORT hos Redeye. BONESUPPORT (Q3 Review): A compelling setup for 2027.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cbiovica-international%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fbiovica-rights-issue-outcome-announced 2026-10-27T09:00:46.952Z

Biovica International hos Redeye. Biovica: Rights issue outcome announced.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cbioinvent-international%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fbioinvent-new-recist-context-to-bi-1808-data 2026-10-27T09:00:46.952Z

Bioinvent International hos Redeye. BioInvent: New RECIST Context to BI-1808 Data.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cbioinvent-international%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fbioinvent-larger-cohort-confirms-bi-1808-efficacy 2026-10-27T09:00:46.952Z

Bioinvent International hos Redeye. BioInvent: Larger Cohort Confirms BI-1808 Efficacy.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cbinero-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fbinero-group-q3-review-figures-support-current-forecast-outlook-remains-healthy 2026-10-27T09:00:46.952Z

Binero Group hos Redeye. Binero Group (Q3 Review): Figures Support Current Forecast; Outlook Remains Healthy.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cavtech-sweden%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Favtech-q3-review-first-new-airline-pushed-into-2027-value-just-above-bear 2026-10-27T09:00:46.952Z

Avtech Sweden hos Redeye. AVTECH (Q3 Review): First new airline pushed into 2027; value just above bear.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cannexin-pharmaceuticals%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fannexin-q3-review-fully-recruited-study 2026-10-27T09:00:46.952Z

Annexin Pharmaceuticals hos Redeye. Annexin (Q3 Review): Fully recruited study.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Calligator-bioscience%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Falligator-bioscience-q3-review-partnering-mitazalimab-to-fund-hlx22 2026-10-27T09:00:46.952Z

Alligator Bioscience hos Redeye. Alligator Bioscience (Q3 Review): Partnering Mitazalimab to Fund HLX22.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cacarix%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Facarix-regulatory-approval-for-the-cadscor-system-in-saudi-arabia 2026-10-27T09:00:46.952Z

Acarix hos Redeye. Acarix: Regulatory approval for the CADScor System in Saudi Arabia.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ckalqyl%7Cupsales%7Chttps%3A%2F%2Fkalqyl.se%2Fvd-intervjuer%2Fupsales-vd-intervju-med-johan-kallblad-om-q3-26 2026-10-27T09:00:46.952Z

Upsales Technology hos Kalqyl. Upsales: VD-intervju med Johan Kallblad om Q3'26.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ckalqyl%7Cupsales%7Chttps%3A%2F%2Fkalqyl.se%2Fanalyser%2Fupsales-rapportkommentar-q3-26 2026-10-27T09:00:46.952Z

Upsales Technology hos Kalqyl. Upsales: Rapportkommentar Q3'26.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ckalqyl%7Cplejd%7Chttps%3A%2F%2Fkalqyl.se%2Fanalyser%2Fplejd-rapportkommentar-q3-26 2026-10-27T09:00:46.952Z

Plejd hos Kalqyl. Plejd: Rapportkommentar Q3’26.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ckalqyl%7Cbriox%7Chttps%3A%2F%2Fkalqyl.se%2Fvd-intervjuer%2Fbriox-vd-intervju-med-mikael-lindblom-om-q3-26 2026-10-27T09:00:46.952Z

Briox hos Kalqyl. Briox: VD-intervju med Mikael Lindblom om Q3'26.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ckalqyl%7Cai-revenue-assistant-software%7Chttps%3A%2F%2Fkalqyl.se%2Fvd-intervjuer%2Faira-vd-intervju-med-daniel-wikberg-angaende-q3-26 2026-10-27T09:00:46.952Z

AIRA hos Kalqyl. Aira: VD-intervju med Daniel Wikberg angående Q3'26.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ckalqyl%7Cai-revenue-assistant-software%7Chttps%3A%2F%2Fkalqyl.se%2Fanalyser%2Faira-rapportkommentar-q3-26 2026-10-27T09:00:46.952Z

AIRA hos Kalqyl. Aira: Rapportkommentar Q3'26.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ckalqyl%7Cacuvi%7Chttps%3A%2F%2Fkalqyl.se%2Fvd-intervjuer%2Facuvi-vd-intervju-med-nils-sjoholm-om-q3-26 2026-10-27T09:00:46.952Z

Acuvi hos Kalqyl. Acuvi: VD-intervju med Nils Sjöholm om Q3'26.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cimpala-nordic%7Cprebona%7Chttps%3A%2F%2Fimpalanordic.se%2Fanalyser%2Fprebona-bevakningskommentar-2-avtal 2026-10-27T09:00:46.952Z

Prebona hos Impala Nordic. Prebona – Bevakningskommentar.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cdagens-bors%7Cwyld-networks%7Chttps%3A%2F%2Fdagensbors.se%2Fteknisk-analys-wyld-networks-drone-chip%2F 2026-10-27T09:00:46.952Z

Wyld Networks hos Dagens Börs. TEKNISK ANALYS: Wyld Networks – drone chip.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cdagens-bors%7Cwhite-pearl%7Chttps%3A%2F%2Fdagensbors.se%2Fteknisk-analys-wptg-intakterna-pa-ath%2F 2026-10-27T09:00:46.952Z

White Pearl Technology Group hos Dagens Börs. TEKNISK ANALYS: WPTG – intäkterna på ATH!.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cdagens-bors%7Ctitania%7Chttps%3A%2F%2Fdagensbors.se%2Fteknisk-analys-titania-substansvarde-26kr%2F 2026-10-27T09:00:46.952Z

Titania Holding hos Dagens Börs. TEKNISK ANALYS: Titania, substansvärde 26kr.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cdagens-bors%7Cmresell%7Chttps%3A%2F%2Fdagensbors.se%2Fteknisk-analys-mresell%2F 2026-10-27T09:00:46.952Z

mResell Holding hos Dagens Börs. TEKNISK ANALYS: mResell.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cdagens-bors%7Ccandles-scandinavia%7Chttps%3A%2F%2Fdagensbors.se%2Fteknisk-analys-candles-scandinavia-8%2F 2026-10-27T09:00:46.952Z

Candles Scandinavia hos Dagens Börs. TEKNISK ANALYS: Candles Scandinavia.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cdagens-bors%7Cbiofrigas%7Chttps%3A%2F%2Fdagensbors.se%2Ferik-fromell-vd-biofrigas-order-i-sikte%2F 2026-10-27T09:00:46.952Z

Biofrigas hos Dagens Börs. Erik Fromell VD Biofrigas – Order i sikte.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cvertiseit%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fvertiseit-organic-growth-acceleration-margin-expansion-q3-review 2026-10-27T09:00:46.952Z

Vertiseit hos Carnegie/Penser uppdragsanalys. Vertiseit: Organic growth acceleration, margin expansion – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cvertiseit%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fvertiseit-accelerating-organic-arr-growth-q3-initial 2026-10-27T09:00:46.952Z

Vertiseit hos Carnegie/Penser uppdragsanalys. Vertiseit: Accelerating organic ARR growth – Q3 initial.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cterranor-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fterranor-focus-on-the-margin-q3-preview 2026-10-27T09:00:46.952Z

Terranor Group hos Carnegie/Penser uppdragsanalys. Terranor: Focus on the margin – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Csvedbergs%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fsvedbergs-group-we-expect-a-margin-recovery-in-2027-q3-review 2026-10-27T09:00:46.952Z

Svedbergs Group hos Carnegie/Penser uppdragsanalys. Svedbergs Group: We expect a margin recovery in 2027 – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cspago-nanomedical%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fspago-nanomedical-move-to-go-private 2026-10-27T09:00:46.952Z

Spago Nanomedical hos Carnegie/Penser uppdragsanalys. Spago Nanomedical: Move to go private.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Csolar-foods%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fsolar-foods-godert-zijlstra-to-leave-solar-foods-at-year-end-2026 2026-10-27T09:00:46.952Z

Solar Foods hos Carnegie/Penser uppdragsanalys. Solar Foods: Godert Zijlstra to leave Solar Foods at year-end 2026.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cscanfil%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fscanfil-strong-quarter-and-improved-visibility-q3-review 2026-10-27T09:00:46.952Z

Scanfil hos Carnegie/Penser uppdragsanalys. Scanfil: Strong quarter and improved visibility – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cscanfil%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fscanfil-26-adj-ebita-growth-y-y-q3-initial-comment 2026-10-27T09:00:46.952Z

Scanfil hos Carnegie/Penser uppdragsanalys. Scanfil: 26% adj. EBITA growth Y/Y – Q3 initial comment.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cqualisys%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fqualisys-delayed-orders-weigh-on-results-q3-update 2026-10-27T09:00:46.952Z

Qualisys hos Carnegie/Penser uppdragsanalys. Qualisys: Delayed orders weigh on results – Q3 update.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cqualisys%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fqualisys-building-towards-a-stronger-h2-q3-preview 2026-10-27T09:00:46.952Z

Qualisys hos Carnegie/Penser uppdragsanalys. Qualisys: Building towards a stronger H2 – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cpricer%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fpricer-strong-margins-maintained-q3-review 2026-10-27T09:00:46.952Z

Pricer hos Carnegie/Penser uppdragsanalys. Pricer: Strong margins maintained – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cpricer%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fpricer-impressive-gross-margin-expansion-and-ebit-q3-initial 2026-10-27T09:00:46.952Z

Pricer hos Carnegie/Penser uppdragsanalys. Pricer: Impressive gross margin expansion and EBIT – Q3 initial.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cpricer%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbactiguard-licence-engine-gaining-momentum-q3-review 2026-10-27T09:00:46.952Z

Pricer hos Carnegie/Penser uppdragsanalys. Bactiguard: Licence engine gaining momentum – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cpowercell-sweden%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fpowercell-timing-effects-largely-explain-the-weakness-q3-initial 2026-10-27T09:00:46.952Z

PowerCell Sweden hos Carnegie/Penser uppdragsanalys. PowerCell: Timing effects largely explain the weakness – Q3 initial.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cpowercell-sweden%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fpowercell-preparing-for-a-wide-range-of-outcomes-in-2027-q3-review 2026-10-27T09:00:46.952Z

PowerCell Sweden hos Carnegie/Penser uppdragsanalys. PowerCell: Preparing for a wide range of outcomes in 2027 – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cpaxman%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fpaxman-ibbm-momentum-versus-opex-q3-preview 2026-10-27T09:00:46.952Z

Paxman hos Carnegie/Penser uppdragsanalys. Paxman: IBBM momentum versus opex – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cortoma%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fortoma-secures-breakthrough-commercial-order-from-partner 2026-10-27T09:00:46.952Z

Ortoma hos Carnegie/Penser uppdragsanalys. Ortoma: Secures breakthrough commercial order from partner.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cnet-insight%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fnet-insight-signs-of-increased-market-activity-q3-preview 2026-10-27T09:00:46.952Z

Net Insight hos Carnegie/Penser uppdragsanalys. Net Insight: Signs of increased market activity – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cmildef-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fmildef-group-stronger-backlog-supports-2027-outlook-q3-review 2026-10-27T09:00:46.952Z

MilDef Group hos Carnegie/Penser uppdragsanalys. MilDef Group: Stronger backlog supports 2027 outlook – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cmildef-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fmildef-group-backlog-visibility-supports-2027-outlook-q3-initial-comment 2026-10-27T09:00:46.952Z

MilDef Group hos Carnegie/Penser uppdragsanalys. MilDef Group: Backlog visibility supports 2027 outlook – Q3 initial comment.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cmicro-systemation%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fmicro-systemation-strong-momentum-multiple-growth-drivers-q3-review 2026-10-27T09:00:46.952Z

Micro Systemation hos Carnegie/Penser uppdragsanalys. Micro Systemation: Strong momentum, multiple growth drivers – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cmicro-systemation%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fmicro-systemation-customer-breach-msab-technology-intact 2026-10-27T09:00:46.952Z

Micro Systemation hos Carnegie/Penser uppdragsanalys. Micro Systemation: Customer breach – MSAB technology intact.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cmicro-systemation%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fmicro-systemation-a-record-quarter-q3-initial-comment 2026-10-27T09:00:46.952Z

Micro Systemation hos Carnegie/Penser uppdragsanalys. Micro Systemation: A record quarter – Q3 initial comment.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Clindex-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Flindex-group-strong-performance-across-the-board-q3-review 2026-10-27T09:00:46.952Z

Lindex Group hos Carnegie/Penser uppdragsanalys. Lindex Group: Strong performance across the board – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Clindex-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Flindex-group-many-contributors-to-strong-group-margins-q3-initial 2026-10-27T09:00:46.952Z

Lindex Group hos Carnegie/Penser uppdragsanalys. Lindex Group: Many contributors to strong group margins – Q3 initial.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ckebni%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fkebni-ready-to-scale-but-orders-must-follow-q3-initial-comment 2026-10-27T09:00:46.952Z

Kebni hos Carnegie/Penser uppdragsanalys. Kebni: Ready to scale, but orders must follow – Q3 initial comment.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ckebni%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fkebni-q3-26-rapportintervju 2026-10-27T09:00:46.952Z

Kebni hos Carnegie/Penser uppdragsanalys. Kebni - Q3 (26) - Rapportintervju.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ckebni%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fkebni-pipeline-conversion-remains-the-key-catalyst-q3-review 2026-10-27T09:00:46.952Z

Kebni hos Carnegie/Penser uppdragsanalys. Kebni: Pipeline conversion remains the key catalyst – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cidun-industrier%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fidun-industrier-earnings-beat-driven-by-service-and-maintenance-q3-initial 2026-10-27T09:00:46.952Z

Idun Industrier hos Carnegie/Penser uppdragsanalys. Idun Industrier: Earnings beat driven by Service & Maintenance – Q3 initial.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cidun-industrier%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fidun-industrier-a-strong-comeback-after-the-weaker-q2-q3-review 2026-10-27T09:00:46.952Z

Idun Industrier hos Carnegie/Penser uppdragsanalys. Idun Industrier: A strong comeback after the weaker Q2 – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ciconovo%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Ficonovo-management-upbeat-on-near-term-deal-q3-review 2026-10-27T09:00:46.952Z

Iconovo hos Carnegie/Penser uppdragsanalys. Iconovo: Management upbeat on near-term deal – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Chanza%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fhanza-bmk-margin-recovery-continues-q3-initial-comment 2026-10-27T09:00:46.952Z

HANZA hos Carnegie/Penser uppdragsanalys. HANZA: BMK margin recovery continues – Q3 initial comment.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Chaki-safety%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fhaki-safety-organic-weakness-slows-recovery-q3-initial-take 2026-10-27T09:00:46.952Z

HAKI Safety hos Carnegie/Penser uppdragsanalys. HAKI Safety: Organic weakness slows recovery – Q3 initial take.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Chaki-safety%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fhaki-safety-order-delays-cloud-recovery-fv-lowered-q3-review 2026-10-27T09:00:46.952Z

HAKI Safety hos Carnegie/Penser uppdragsanalys. HAKI Safety: Order delays cloud recovery; FV lowered – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cependion%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fependion-energy-end-market-likely-to-remain-strong-q3-review 2026-10-27T09:00:46.952Z

Ependion hos Carnegie/Penser uppdragsanalys. Ependion: Energy end-market likely to remain strong – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cependion%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fependion-demand-remains-strong 2026-10-27T09:00:46.952Z

Ependion hos Carnegie/Penser uppdragsanalys. Ependion – demand remains strong.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cependion%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fependion-all-time-high-ebita-q3-initial 2026-10-27T09:00:46.952Z

Ependion hos Carnegie/Penser uppdragsanalys. Ependion: All-time high EBITA – Q3 initial.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Celanders%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Felanders-signs-of-recovery-in-fashion-q3-review 2026-10-27T09:00:46.952Z

Elanders hos Carnegie/Penser uppdragsanalys. Elanders: Signs of recovery in fashion – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Celanders%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Felanders-sequentially-stable-demand-q3-preview 2026-10-27T09:00:46.952Z

Elanders hos Carnegie/Penser uppdragsanalys. Elanders: Sequentially stable demand – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Celanders%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Felanders-6-y-y-organic-growth-q3-initial 2026-10-27T09:00:46.952Z

Elanders hos Carnegie/Penser uppdragsanalys. Elanders: 6% Y/Y organic growth – Q3 initial.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ccdon%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fcdon-strong-growth-fending-off-toll-uncertainty-q3-initial 2026-10-27T09:00:46.952Z

CDON hos Carnegie/Penser uppdragsanalys. CDON: Strong growth fending off toll uncertainty – Q3 initial.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ccdon%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fcdon-fyndiq-surprises-amid-uncertainty-q3-review 2026-10-27T09:00:46.952Z

CDON hos Carnegie/Penser uppdragsanalys. CDON: Fyndiq surprises amid uncertainty – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ccalviks%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fcalviks-acquisitions-aplenty-financing-secured-q3-preview 2026-10-27T09:00:46.952Z

Calviks hos Carnegie/Penser uppdragsanalys. Calviks: Acquisitions aplenty, financing secured – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ccalviks%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fcalviks-acquisitions-aplenty-financing-secured 2026-10-27T09:00:46.952Z

Calviks hos Carnegie/Penser uppdragsanalys. Calviks - Acquisitions aplenty, financing secured.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ccag-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fcag-q3-26-rapportintervju 2026-10-27T09:00:46.952Z

CAG Group hos Carnegie/Penser uppdragsanalys. CAG - Q3 (26) - Rapportintervju.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ccag-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fcag-group-higher-utilisation-drives-organic-growth-q3-initial-comment 2026-10-27T09:00:46.952Z

CAG Group hos Carnegie/Penser uppdragsanalys. CAG Group: Higher utilisation drives organic growth – Q3 initial comment.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ccag-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fcag-group-gradual-recovery-resilient-fundamentals-q3-review 2026-10-27T09:00:46.952Z

CAG Group hos Carnegie/Penser uppdragsanalys. CAG Group: Gradual recovery, resilient fundamentals – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbonava%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbonava-german-weakness-delays-recovery-q3-initial-take 2026-10-27T09:00:46.952Z

Bonava hos Carnegie/Penser uppdragsanalys. Bonava: German weakness delays recovery – Q3 initial take.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbonava%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbonava-german-slowdown-delays-recovery-q3-review 2026-10-27T09:00:46.952Z

Bonava hos Carnegie/Penser uppdragsanalys. Bonava: German slowdown delays recovery – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbonava%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fanalyspodden-avsnitt-387-bonava-om-bostadsmarknaden-och-vagen-framat 2026-10-27T09:00:46.952Z

Bonava hos Carnegie/Penser uppdragsanalys. Analyspodden - Avsnitt 387 - Bonava om bostadsmarknaden och vägen framåt.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbokusgruppen%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbokusgruppen-strong-growth-from-acquisition-q3-review 2026-10-27T09:00:46.952Z

Bokusgruppen hos Carnegie/Penser uppdragsanalys. Bokusgruppen: Strong growth from acquisition – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbokusgruppen%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbokusgruppen-q3-26-rapportintervju 2026-10-27T09:00:46.952Z

Bokusgruppen hos Carnegie/Penser uppdragsanalys. Bokusgruppen - Q3 (26) - Rapportintervju.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbokusgruppen%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbokusgruppen-acquisition-support-some-online-uncertainty-q3-preview 2026-10-27T09:00:46.952Z

Bokusgruppen hos Carnegie/Penser uppdragsanalys. Bokusgruppen: Acquisition support, some online uncertainty – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbjorn-borg%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbjorn-borg-back-to-growth-trajectory-q3-initial 2026-10-27T09:00:46.952Z

Björn Borg hos Carnegie/Penser uppdragsanalys. Björn Borg: Back to growth trajectory – Q3 initial.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbjorn-borg%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbjorn-borg-back-to-growth-margin-expansion-continues-q3-review 2026-10-27T09:00:46.952Z

Björn Borg hos Carnegie/Penser uppdragsanalys. Björn Borg: Back to growth, margin expansion continues – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbesqab%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbesqab-margin-strength-supports-recovery-q3-initial-take 2026-10-27T09:00:46.952Z

Besqab hos Carnegie/Penser uppdragsanalys. Besqab: Margin strength supports recovery – Q3 initial take.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbesqab%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbesqab-margin-strength-brings-targets-closer-q3-review 2026-10-27T09:00:46.952Z

Besqab hos Carnegie/Penser uppdragsanalys. Besqab: Margin strength brings targets closer – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbergman-and-beving%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbergman-and-beving-grona-skott 2026-10-27T09:00:46.952Z

Bergman & Beving hos Carnegie/Penser uppdragsanalys. Bergman & Beving - Gröna skott.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbergman-and-beving%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbergman-and-beving-green-shoots-q2-review 2026-10-27T09:00:46.952Z

Bergman & Beving hos Carnegie/Penser uppdragsanalys. Bergman & Beving: Green shoots – Q2 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbergman-and-beving%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbergman-and-beving-continued-ebita-growth-q2-initial 2026-10-27T09:00:46.952Z

Bergman & Beving hos Carnegie/Penser uppdragsanalys. Bergman & Beving: Continued EBITA growth – Q2 initial.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbactiguard-holding%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbactiguard-strong-bd-and-stronger-ebitda-q3-initial 2026-10-27T09:00:46.952Z

Bactiguard Holding hos Carnegie/Penser uppdragsanalys. Bactiguard: Strong BD and stronger EBITDA – Q3 initial.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Calm-equity%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Falm-equity-starts-accelerating-cash-flow-lagging-q3-initial-take 2026-10-27T09:00:46.952Z

ALM Equity hos Carnegie/Penser uppdragsanalys. ALM Equity: Starts accelerating; cash flow lagging – Q3 initial take.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Calm-equity%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Falm-equity-starting-to-accelerate-cash-flow-lags-q3-review 2026-10-27T09:00:46.952Z

ALM Equity hos Carnegie/Penser uppdragsanalys. ALM Equity: Starting to accelerate, cash flow lags – Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarlsquare%7Czinzino%7Chttps%3A%2F%2Fcarlsquare.com%2Fsv%2Fanalys-zinzino-kv3-2026-preview-hogre-lonsamhet-trots-en-viss-tillvaxtavmattning%2F 2026-10-27T09:00:46.952Z

Zinzino hos Carlsquare Equity Research. Analys Zinzino kv3 2026: Preview - Högre lönsamhet trots en viss tillväxtavmattning.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarlsquare%7Ccdon%7Chttps%3A%2F%2Fcarlsquare.com%2Fsv%2Fequity-research-cdon-q3-2026-strong-gmv-momentum-and-fyndiq-relief%2F 2026-10-27T09:00:46.952Z

CDON hos Carlsquare Equity Research. Equity research CDON Q3 2026: Strong GMV momentum and Fyndiq relief.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarlsquare%7Ccdon%7Chttps%3A%2F%2Fcarlsquare.com%2Fsv%2Fequity-research-cdon-q3-2026-first-impression-better-growth-than-expected%2F 2026-10-27T09:00:46.952Z

CDON hos Carlsquare Equity Research. Equity research CDON Q3 2026: First impression - Better growth than expected.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarlsquare%7Calm-equity%7Chttps%3A%2F%2Fcarlsquare.com%2Fsv%2Fanalys-alm-equity-kv3-2026-vinstlyft-drojer-trots-hogre-byggaktivitet%2F 2026-10-27T09:00:46.952Z

ALM Equity hos Carlsquare Equity Research. Analys ALM Equity, kv3 2026: Vinstlyft dröjer trots högre byggaktivitet.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarlsquare%7Calm-equity%7Chttps%3A%2F%2Fcarlsquare.com%2Fsv%2Fanalys-alm-equity-kv3-2026-resultat-som-vantat-trots-laga-intakter%2F 2026-10-27T09:00:46.952Z

ALM Equity hos Carlsquare Equity Research. Analys ALM Equity, kv3 2026: Resultat som väntat trots låga intäkter.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Csynexo-group%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Fkommentar-pa-synexos-avsiktsforklaring-avseende-ett-andra-forvarv-inom-hosting 2026-10-27T09:00:46.952Z

Synexo Group hos Analyst Group. Kommentar på Synexos avsiktsförklaring avseende ett andra förvärv inom hosting.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Cpolight%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Fpreview-comment-on-polights-q3-26-interim-report 2026-10-27T09:00:46.952Z

poLight hos Analyst Group. Preview Comment on poLight’s Q3-26 Interim Report.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Cmahvie-minerals%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Fkommentar-pa-mahvie-minerals-borresultat-fran-akerberg 2026-10-27T09:00:46.952Z

Mahvie Minerals hos Analyst Group. Kommentar på Mahvie Minerals borresultat från Åkerberg.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Clumito%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Fkommentar-pa-utfallet-av-lumitos-pilotprojekt-med-navinci-diagnostics 2026-10-27T09:00:46.952Z

Lumito hos Analyst Group. Kommentar på utfallet av Lumitos pilotprojekt med Navinci Diagnostics.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Clumito%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Fkommentar-pa-lumitos-partnerskap-med-cro-bolaget-aurevia 2026-10-27T09:00:46.952Z

Lumito hos Analyst Group. Kommentar på Lumitos partnerskap med CRO-bolaget Aurevia.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Cemb-mission-bound%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Fkommentar-pa-emb-mission-bounds-avtal-om-forvarv-av-megabet-plus 2026-10-27T09:00:46.952Z

EMB Mission Bound hos Analyst Group. Kommentar på EMB Mission Bounds avtal om förvärv av MegaBet Plus.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalysguiden%7Cprisma-properties%7Chttps%3A%2F%2Fwww.aktiespararna.se%2Fanalyser%2Fprisma-properties-kraftig-resultatokning-i-tredje-kvartalet 2026-10-27T09:00:46.952Z

Prisma Properties hos Analysguiden. Prisma Properties: Kraftig resultatökning i tredje kvartalet.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalysguiden%7Cfastpartner%7Chttps%3A%2F%2Fwww.aktiespararna.se%2Fanalyser%2Ffastpartner-fastpartner-ser-positiva-sentiment-i-marknaden 2026-10-27T09:00:46.952Z

Fastpartner hos Analysguiden. Fastpartner: Fastpartner ser positiva sentiment i marknaden.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalysguiden%7Ceastnine%7Chttps%3A%2F%2Fwww.aktiespararna.se%2Fanalyser%2Fforsta-intryck-eastnine-forvarvet-av-the-bridge-har-slutforts 2026-10-27T09:00:46.952Z

Eastnine hos Analysguiden. Första intryck Eastnine: Förvärvet av The Bridge har slutförts.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalysguiden%7Ceastnine%7Chttps%3A%2F%2Fwww.aktiespararna.se%2Fanalyser%2Feastnine-warszawa-ar-numera-eastnines-storsta-marknad 2026-10-27T09:00:46.952Z

Eastnine hos Analysguiden. Eastnine: Warszawa är numera Eastnines största marknad.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalysguiden%7Cbyggpartner-gruppen%7Chttps%3A%2F%2Fwww.aktiespararna.se%2Fanalyser%2Fbyggpartner-gruppen-ofortjant-rabattvarderad 2026-10-27T09:00:46.952Z

ByggPartner Gruppen hos Analysguiden. Byggpartner Gruppen: Oförtjänt rabattvärderad.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalysguiden%7Cbeijer-alma%7Chttps%3A%2F%2Fwww.aktiespararna.se%2Fanalyser%2Fbeijer-alma-okar-marginalerna-och-laddar-for-nya-forvarv 2026-10-27T09:00:46.952Z

Beijer Alma hos Analysguiden. Beijer Alma: Ökar marginalerna och laddar för nya förvärv.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cq-beyond%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fq-beyond-solid-momentum-in-q3-new-sales 2026-10-19T08:54:21.585Z

q.beyond hos Redeye. q.beyond: Solid momentum in Q3 new sales.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cinvisio%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Finvisio-q3-preview-order-intake-in-focus 2026-10-19T08:54:21.585Z

Invisio hos Redeye. Invisio (Q3 Preview): Order intake in focus.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Ccarasent%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fcarasent-q3-review-infosolutions-and-medsum-taking-the-lead 2026-10-19T08:54:21.585Z

Carasent hos Redeye. Carasent (Q3 Review): Infosolutions and Medsum taking the lead.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ckalqyl%7Cplejd%7Chttps%3A%2F%2Fkalqyl.se%2Fvd-intervjuer%2Fplejd-vd-intervju-med-babak-esfahani-angaende-q3-26 2026-10-19T08:54:21.585Z

Plejd hos Kalqyl. Plejd: VD-intervju med Babak Esfahani angående Q3'26.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cimpala-nordic%7Cseamless-distribution-systems%7Chttps%3A%2F%2Fimpalanordic.se%2Fanalyser%2Fcoverage-comment-seamless-distribution-systems 2026-10-19T08:54:21.585Z

Seamless Distribution Systems hos Impala Nordic. Coverage comment – Seamless Distribution Systems.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cdagens-bors%7Cbiofrigas%7Chttps%3A%2F%2Fdagensbors.se%2Ferik-fromell-vd-biofrigas-uppskalningen%2F 2026-10-19T08:54:21.585Z

Biofrigas hos Dagens Börs. Erik Fromell, VD Biofrigas – uppskalningen.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cpowercell-sweden%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fpowercell-recovery-yet-to-be-seen-q3-preview 2026-10-19T08:54:21.585Z

PowerCell Sweden hos Carnegie/Penser uppdragsanalys. PowerCell: Recovery yet to be seen – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cgig-software%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fgig-software-888africa-not-yet-visible-in-the-numbers-q3-preview 2026-10-19T08:54:21.585Z

GiG Software hos Carnegie/Penser uppdragsanalys. GiG Software: 888Africa not yet visible in the numbers – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ccag-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fcag-group-market-stabilisation-supports-the-2027-outlook-q3-preview 2026-10-19T08:54:21.585Z

CAG Group hos Carnegie/Penser uppdragsanalys. CAG Group: Market stabilisation supports the 2027 outlook – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cbergman-and-beving%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fbergman-and-beving-expecting-deal-activity-to-pick-up-in-fiscal-h2-q2-preview 2026-10-19T08:54:21.585Z

Bergman & Beving hos Carnegie/Penser uppdragsanalys. Bergman & Beving: Expecting deal activity to pick up in fiscal H2 – Q2 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Calbert%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Feeducation-albert-progress-towards-2026-financial-targets-q3-preview 2026-10-19T08:54:21.585Z

eEducation Albert hos Carnegie/Penser uppdragsanalys. eEducation Albert: Progress towards 2026 financial targets – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cvhcorp%7Caxichem%7Chttps%3A%2F%2Fwww.vhcorp.se%2Ftjanster%2Fmarknadsfokus%2Faxichem%2Faxichem-axivite-order-i-ny-distributionskanal 2026-10-16T08:11:48.539Z

aXichem hos Västra Hamnen Corporate Finance. aXichem: aXivite-order i ny distributionskanal.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cxvivo-perfusion%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fxvivo-perfusion-q3-preview-heart-opportunity-approaches 2026-10-16T08:11:48.539Z

Xvivo Perfusion hos Redeye. Xvivo Perfusion (Q3 preview): Heart opportunity approaches.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cxbrane-biopharma%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fxbrane-biopharma-xdivane-pivotal-study-fully-recruited 2026-10-16T08:11:48.539Z

Xbrane Biopharma hos Redeye. Xbrane Biopharma: Xdivane pivotal study fully recruited.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cvitrolife%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fvitrolife-q3-preview-earnings-on-the-rise-fx-adds-support 2026-10-16T08:11:48.539Z

Vitrolife hos Redeye. Vitrolife (Q3 preview): Earnings on the rise, FX adds support.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cstille%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fweekly-edge-case-stille 2026-10-16T08:11:48.539Z

Stille hos Redeye. Weekly Edge Case – Stille.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Csiljansvik%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fsiljansvik-consolidating-ownership-ahead-of-next-investment-cycle 2026-10-16T08:11:48.539Z

Siljansvik hos Redeye. Siljansvik: Consolidating ownership ahead of next investment cycle.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cscibase-holding%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fscibase-first-private-payer-coverage-in-the-us 2026-10-16T08:11:48.539Z

SciBase Holding hos Redeye. SciBase: First private payer coverage in the US.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cplejd%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fplejd-q3-2026-preview-lpn-01-ramps-but-tough-comps-in-sweden 2026-10-16T08:11:48.539Z

Plejd hos Redeye. Plejd (Q3 2026 Preview): LPN-01 ramps, but tough comps in Sweden.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Concopeptides%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Foncopeptides-sek100m-directed-issue-funds-glioblastoma 2026-10-16T08:11:48.539Z

Oncopeptides hos Redeye. Oncopeptides: SEK100m Directed Issue Funds Glioblastoma.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Concopeptides%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Foncopeptides-pdc-platform-crosses-the-blood-brain-barrier 2026-10-16T08:11:48.539Z

Oncopeptides hos Redeye. Oncopeptides: PDC Platform Crosses the Blood-Brain Barrier.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Ckd-ventures%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fkdventures-safety-pause-at-modus-delays-readout 2026-10-16T08:11:48.539Z

KD Ventures hos Redeye. KDventures: Safety Pause at Modus Delays Readout.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cincoax-networks%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fincoax-deeply-discounted-rights-issue-secures-funding 2026-10-16T08:11:48.539Z

InCoax Networks hos Redeye. InCoax: Deeply discounted rights issue secures funding.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Ci-tech%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fi-tech-signs-aquaculture-license-agreement 2026-10-16T08:11:48.539Z

I-tech hos Redeye. I-Tech: Signs Aquaculture license agreement.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Chacksaw%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fhacksaw-q3-results-below-expectations 2026-10-16T08:11:48.539Z

Hacksaw hos Redeye. Hacksaw: Q3-results below expectations.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Chacksaw%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fhacksaw-broadens-product-portfolio-with-prediction-markets-offer 2026-10-16T08:11:48.539Z

Hacksaw hos Redeye. Hacksaw: Broadens product portfolio with prediction markets offer.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cfreja-eid-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Ffreja-eid-preliminary-q3-arr-growth-roughly-as-expected 2026-10-16T08:11:48.539Z

Freja eID Group hos Redeye. Freja eID (Preliminary Q3): ARR growth roughly as expected.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Celicera-therapeutics%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Felicera-strong-finish-to-carma-phase-i 2026-10-16T08:11:48.539Z

Elicera Therapeutics hos Redeye. Elicera: Strong finish to CARMA Phase I.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cavtech-sweden%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Favtech-key-figures-show-a-softer-landing-than-feared 2026-10-16T08:11:48.539Z

Avtech Sweden hos Redeye. AVTECH: Key figures show a softer landing than feared.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cavensia%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Favensia-slightly-upbeat-sales-numbers-for-september-and-q3-fuelled-by-strong-growth-in-im 2026-10-16T08:11:48.539Z

Avensia hos Redeye. Avensia: Slightly upbeat sales numbers for September and Q3 fuelled by strong growth in IM.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Credeye%7Cascelia-pharma%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fredeye%2Fascelia-our-comment-on-the-fda-minutes 2026-10-16T08:11:48.539Z

Ascelia Pharma hos Redeye. Ascelia: Our comment on the FDA minutes.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ckalqyl%7Cjondetech-sensors%7Chttps%3A%2F%2Fkalqyl.se%2Fanalyser%2Fjondetech-sensors-rapportkommentar-q3-26 2026-10-16T08:11:48.539Z

JonDeTech Sensors hos Kalqyl. JonDeTech Sensors: Rapportkommentar Q3'26.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cdagens-bors%7Cxoma%7Chttps%3A%2F%2Fdagensbors.se%2Fteknisk-analys-xoma-2066-ny-framgang%2F 2026-10-16T08:11:48.539Z

Xoma hos Dagens Börs. TEKNISK ANALYS: XOMA (+20,66%) ny framgång.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cdagens-bors%7Cpeptonic%7Chttps%3A%2F%2Fdagensbors.se%2Fteknisk-analys-peptonic-medical-okar-i-usa%2F 2026-10-16T08:11:48.539Z

Peptonic Medical hos Dagens Börs. TEKNISK ANALYS: Peptonic Medical ökar i USA.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Cdagens-bors%7Cmysafety%7Chttps%3A%2F%2Fdagensbors.se%2Fteknisk-analys-mysafety-135-kr-utdelning%2F 2026-10-16T08:11:48.539Z

MySafety Group hos Dagens Börs. TEKNISK ANALYS: MySafety 1,35 kr/utdelning.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cvivestoab%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fvivesto-key-congress-exposure-for-paccal-vet-data 2026-10-16T08:11:48.539Z

Vivesto hos Carnegie/Penser uppdragsanalys. Vivesto: Key congress exposure for Paccal Vet data.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cvertiseit%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fvertiseit-support-for-arr-organic-growth-acceleration-q3-preview 2026-10-16T08:11:48.539Z

Vertiseit hos Carnegie/Penser uppdragsanalys. Vertiseit: Support for ARR organic growth acceleration – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Csvedbergs%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fsvedbergs-group-looking-for-the-margin-to-recover-in-2027e-q3-preview 2026-10-16T08:11:48.539Z

Svedbergs Group hos Carnegie/Penser uppdragsanalys. Svedbergs Group: Looking for the margin to recover in 2027e – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Crelais-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Frelais-group-we-expect-flattish-earnings-q3-preview 2026-10-16T08:11:48.539Z

Relais Group hos Carnegie/Penser uppdragsanalys. Relais Group: We expect flattish earnings – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cpricer%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fpricer-deal-secured-with-orange-in-france 2026-10-16T08:11:48.539Z

Pricer hos Carnegie/Penser uppdragsanalys. Pricer: Deal secured with Orange in France.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cpierce-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fpierce-steady-through-a-bumpy-patch-q3-preview 2026-10-16T08:11:48.539Z

Pierce Group hos Carnegie/Penser uppdragsanalys. Pierce: Steady through a bumpy patch – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cossdsign%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fossdsign-q3-too-early-for-the-turnaround-q3-preview 2026-10-16T08:11:48.539Z

OssDsign hos Carnegie/Penser uppdragsanalys. OssDsign: Q3 too early for the turnaround – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cmildef-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fmildef-group-record-order-intake-and-strong-end-to-2026e-q3-preview 2026-10-16T08:11:48.539Z

MilDef Group hos Carnegie/Penser uppdragsanalys. MilDef Group: Record order intake and strong end to 2026e – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cmicro-systemation%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fmicro-systemation-q3-significantly-better-than-expected-q3-preview 2026-10-16T08:11:48.539Z

Micro Systemation hos Carnegie/Penser uppdragsanalys. Micro Systemation: Q3 significantly better than expected – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Clindex-group%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Flindex-group-support-for-cash-flow-growth-in-h2e-q3-preview 2026-10-16T08:11:48.539Z

Lindex Group hos Carnegie/Penser uppdragsanalys. Lindex Group: Support for cash flow growth in H2e – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ckebni%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fkebni-focus-shifts-to-2027-q3-preview 2026-10-16T08:11:48.539Z

Kebni hos Carnegie/Penser uppdragsanalys. Kebni: Focus shifts to 2027 – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Citab-shop-concept%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fitab-group-profit-margin-and-execution-focus-q3-preview 2026-10-16T08:11:48.539Z

ITAB Group hos Carnegie/Penser uppdragsanalys. ITAB Group: Profit margin and execution focus – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cependion%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fependion-focusing-on-demand-in-trains-and-energy-q3-preview 2026-10-16T08:11:48.539Z

Ependion hos Carnegie/Penser uppdragsanalys. Ependion: Focusing on demand in trains and energy – Q3 preview.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ceolus-vind%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fanalyspodden-avsnitt-385-konsten-att-utveckla-framtidens-fornybara-energi-med-eolus 2026-10-16T08:11:48.539Z

Eolus Vind hos Carnegie/Penser uppdragsanalys. Analyspodden - Avsnitt 385 - Konsten att utveckla framtidens förnybara energi med Eolus.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Celicera-therapeutics%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Felicera-therapeutics-phase-i-part-of-the-carma-trial-now-completed 2026-10-16T08:11:48.539Z

Elicera Therapeutics hos Carnegie/Penser uppdragsanalys. Elicera Therapeutics: Phase I part of the CARMA trial now completed.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Celicera-therapeutics%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Felicera-therapeutics-johan-liwing-om-carma-resultaten-och-vagen-mot-fas-iia 2026-10-16T08:11:48.539Z

Elicera Therapeutics hos Carnegie/Penser uppdragsanalys. Elicera Therapeutics - Johan Liwing om CARMA-resultaten och vägen mot Fas IIa.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ccarasent%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fcarasent-strong-q3-should-validate-the-margin-story-initial-comment 2026-10-16T08:11:48.539Z

Carasent hos Carnegie/Penser uppdragsanalys. Carasent: Strong Q3 should validate the margin story – initial comment.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ccarasent%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fcarasent-q3-a-hint-of-the-profitability-potential-q3-review 2026-10-16T08:11:48.539Z

Carasent hos Carnegie/Penser uppdragsanalys. Carasent: Q3 a hint of the profitability potential– Q3 review.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Ccarasent%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fcarasent-q3-26-rapportintervju 2026-10-16T08:11:48.539Z

Carasent hos Carnegie/Penser uppdragsanalys. Carasent - Q3 (26) - Rapportintervju.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarnegie-penser%7Cascelia-pharma%7Chttps%3A%2F%2Fmfn.se%2Fa%2Fcarnegie%2Fascelia-pharma-fda-requests-additional-clinical-evidence 2026-10-16T08:11:48.539Z

Ascelia Pharma hos Carnegie/Penser uppdragsanalys. Ascelia Pharma: FDA requests additional clinical evidence.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Ccarlsquare%7Calm-equity%7Chttps%3A%2F%2Fcarlsquare.com%2Fsv%2Fanalys-alm-equity-kv3-2026-flera-byggstarter-under-kvartalet%2F 2026-10-16T08:11:48.539Z

ALM Equity hos Carlsquare Equity Research. Analys ALM Equity, kv3 2026: Flera byggstarter under kvartalet.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Czenith-energy%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Fcomment-on-reveilles-appointment-of-mike-pompeo-as-proposed-chairman 2026-10-16T08:11:48.539Z

Zenith Energy hos Analyst Group. Comment on Reveille’s Appointment of Mike Pompeo as Proposed Chairman.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Csynexo-group%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Fkommentar-pa-synexos-septemberuppdatering 2026-10-16T08:11:48.539Z

Synexo Group hos Analyst Group. Kommentar på Synexos septemberuppdatering.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Cmodus-therapeutics%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Fkommentar-pa-att-modus-therapeutics-pausar-rekryteringen-i-fas-iia-studien-inom-ckd-med-anemi 2026-10-16T08:11:48.539Z

Modus Therapeutics hos Analyst Group. Kommentar på att Modus Therapeutics pausar rekryteringen i fas IIa-studien inom CKD med anemi.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Cluxbright%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Fkommentar-pa-luxbrights-ytterligare-order-fran-fisica-om-ca-1-msek 2026-10-16T08:11:48.539Z

Luxbright hos Analyst Group. Kommentar på Luxbrights ytterligare order från Fisica om ca 1 MSEK.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Cluxbright%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Fkommentar-pa-luxbrights-ordrar-fran-fisica-om-totalt-ca-34-msek 2026-10-16T08:11:48.539Z

Luxbright hos Analyst Group. Kommentar på Luxbrights ordrar från Fisica om totalt ca 3,4 MSEK.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalyst-group%7Cacucort%7Chttps%3A%2F%2Fanalystgroup.se%2Fanalyser%2Facucort-bjuder-in-till-kapitalmarknadsdag-den-13-oktober 2026-10-16T08:11:48.539Z

AcuCort hos Analyst Group. AcuCort bjuder in till kapitalmarknadsdag den 13 oktober.

https://betalanalysgranskaren.se/logg/#analys_tillagd%7Canalysguiden%7Ccoor-service-management-holding%7Chttps%3A%2F%2Fwww.aktiespararna.se%2Fanalyser%2Finfor-rapporten-coor-en-brytpunkt-narmar-sig 2026-10-16T08:11:48.539Z

Coor Service Management Holding hos Analysguiden. Inför rapporten Coor: En brytpunkt närmar sig.